YS
YUVRAJ SINGH
Dr. Reddy's Laboratories (India), Indian Institute of Technology BHU Varanasi, Kumaun University Department of Pharmacy, Central Drug Research Institute
Employment
-
Dr. Reddy's Laboratories (India) Scientist/Formulation Expert2017 - Present
Education
-
Indian Institute of Technology BHU Varanasi M. Pharmacy
-
Kumaun University Department of Pharmacy B. Pharmacy
-
Central Drug Research Institute Doctorate of Philosophy (Pharmaceutics)
Projects & Funding
Projects & funding information is unavailable.
Publications (27)
- Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate Save
- Paclitaxel-loaded TPGS enriched self-emulsifying carrier causes apoptosis by modulating survivin expression and inhibits tumour growth in syngeneic mammary tumours. Save
- Improved chemotherapy against breast cancer through immunotherapeutic activity of fucoidan decorated electrostatically assembled nanoparticles bearing doxorubicin. Save
- Nanomedicine for the Treatment of Disease From Concept to Application Save
- Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis. Save
- Click Biotinylation of PLGA Template for Biotin Receptor Oriented Delivery of Doxorubicin Hydrochloride in 4T1 Cell-Induced Breast Cancer. Save
- Doxorubicin Hydrochloride Loaded Zymosan-Polyethylenimine Biopolymeric Nanoparticles for Dual 'Chemoimmunotherapeutic' Intervention in Breast Cancer. Save
- Targeting tumor associated macrophages (TAMs) via nanocarriers. Save
- Nanoemulsion: Concepts, development and applications in drug delivery. Save
- Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan. Save